The pneumonia, pneumococcal therapeutic market is estimated to be valued at USD 2.95 Billion in 2025 and is expected to reach USD 5.26 Billion by 2032, growing at a compound annual growth rate (CAGR) of 8.6% from 2025 to 2032 https://anket.livepositively.com/polymyalgia-rheumatica-drugs-market-growth-and-forecast/new=1